Key statistics
On Monday, LENZ Therapeutics Inc (LENZ:NSQ) closed at 13.68, 19.16% above the 52 week low of 11.48 set on Feb 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.01 |
|---|---|
| High | 14.97 |
| Low | 12.90 |
| Bid | 11.40 |
| Offer | 15.00 |
| Previous close | 13.49 |
| Average volume | 817.58k |
|---|---|
| Shares outstanding | 31.29m |
| Free float | 30.44m |
| P/E (TTM) | -- |
| Market cap | 422.10m USD |
| EPS (TTM) | -2.11 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- LENZ Therapeutics to Present at Upcoming Investor Conferences
- LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign
- LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
- LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ™ in the Middle East
- LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
- LENZ Therapeutics to Present at Upcoming Investor Conferences
- LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
- LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
- LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
- LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences
More ▼
